BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 7526922)

  • 1. Selective expression of CD44 messenger RNA splice variants in four high grade human brain tumour cell lines.
    Harn HJ; Lee HS; Ho LI; Lee WH; Ding JH
    Biochem Mol Biol Int; 1994 Jul; 33(4):743-9. PubMed ID: 7526922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The variant mRNA isoform of human metastasis gene (CD44V) detected in the cell lines of human hepatocellular carcinoma.
    Harn HJ; Ho LI; Yu CP; Wang MW; Lee HS; Lin JJ; Lee WH; Isola NR; Cooper DL
    Biochem Mol Biol Int; 1994 Feb; 32(2):233-8. PubMed ID: 7517252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of CD44 variant isoforms with hyaluronic acid and the cytoskeleton in human prostate cancer cells.
    Welsh CF; Zhu D; Bourguignon LY
    J Cell Physiol; 1995 Sep; 164(3):605-12. PubMed ID: 7544357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of the hyaluronan receptors CD44 and RHAMM in human pancreatic cancer cells.
    Abetamann V; Kern HF; Elsässer HP
    Clin Cancer Res; 1996 Sep; 2(9):1607-18. PubMed ID: 9816340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternative splicing of CD44 pre-mRNA in human colorectal tumors.
    Finn L; Dougherty G; Finley G; Meisler A; Becich M; Cooper DL
    Biochem Biophys Res Commun; 1994 Apr; 200(2):1015-22. PubMed ID: 7513991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms.
    Berkman RA; Merrill MJ; Reinhold WC; Monacci WT; Saxena A; Clark WC; Robertson JT; Ali IU; Oldfield EH
    J Clin Invest; 1993 Jan; 91(1):153-9. PubMed ID: 8380810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HuR, a RNA stability factor, is expressed in malignant brain tumors and binds to adenine- and uridine-rich elements within the 3' untranslated regions of cytokine and angiogenic factor mRNAs.
    Nabors LB; Gillespie GY; Harkins L; King PH
    Cancer Res; 2001 Mar; 61(5):2154-61. PubMed ID: 11280780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of CD44 in prostate cancer cells: association with cell proliferation and invasive potential.
    Lokeshwar BL; Lokeshwar VB; Block NL
    Anticancer Res; 1995; 15(4):1191-8. PubMed ID: 7544562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New CD44 splice variants associated with human breast cancers.
    Iida N; Bourguignon LY
    J Cell Physiol; 1995 Jan; 162(1):127-33. PubMed ID: 7529235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different splice variants of CD44 are expressed in gastrinomas but not in other subtypes of endocrine pancreatic tumors.
    Chaudhry A; Gobl A; Eriksson B; Skogseid B; Oberg K
    Cancer Res; 1994 Feb; 54(4):981-6. PubMed ID: 7508823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of CD44 in normal human versus tumor endometrial tissues: possible implication of reduced expression of CD44 in lymph-vascular space involvement of cancer cells.
    Fujita N; Yaegashi N; Ide Y; Sato S; Nakamura M; Ishiwata I; Yajima A
    Cancer Res; 1994 Jul; 54(14):3922-8. PubMed ID: 7518345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of alpha4 chain-containing laminins in human glial tumors identified by gene microarray analysis.
    Ljubimova JY; Lakhter AJ; Loksh A; Yong WH; Riedinger MS; Miner JH; Sorokin LM; Ljubimov AV; Black KL
    Cancer Res; 2001 Jul; 61(14):5601-10. PubMed ID: 11454714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycoprotein nonmetastatic melanoma protein B, a potential molecular therapeutic target in patients with glioblastoma multiforme.
    Kuan CT; Wakiya K; Dowell JM; Herndon JE; Reardon DA; Graner MW; Riggins GJ; Wikstrand CJ; Bigner DD
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):1970-82. PubMed ID: 16609006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Splice variants of CD44 in human cervical cancer stage IB to IIB.
    Kainz C; Kohlberger P; Sliutz G; Tempfer C; Heinzl H; Reinthaller A; Breitenecker G; Koelbl H
    Gynecol Oncol; 1995 Jun; 57(3):383-7. PubMed ID: 7539775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of integrins and CD44 isoforms in non-Hodgkin's lymphomas: CD44 variant isoforms are preferentially expressed in high-grade malignant lymphomas.
    Terpe HJ; Koopmann R; Imhof BA; Günthert U
    J Pathol; 1994 Oct; 174(2):89-100. PubMed ID: 7525912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of CD44 standard and isoforms in human breast cancer xenografts and shedding of soluble forms into serum of nude mice.
    Fichtner I; Dehmel A; Naundorf H; Finke LH
    Anticancer Res; 1997; 17(5A):3633-45. PubMed ID: 9413216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of vascular endothelial growth factor-b in human astrocytoma.
    Gollmer JC; Ladoux A; Gioanni J; Paquis P; Dubreuil A; Chatel M; Frelin C
    Neuro Oncol; 2000 Apr; 2(2):80-6. PubMed ID: 11303624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternative RNA splicing of the hyaluronic acid receptor CD44 in the normal human brain and in brain tumors.
    Nagasaka S; Tanabe KK; Bruner JM; Saya H; Sawaya RE; Morrison RS
    J Neurosurg; 1995 May; 82(5):858-63. PubMed ID: 7536236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD44 expression in astrocytic tumors.
    Ylagan LR; Quinn B
    Mod Pathol; 1997 Dec; 10(12):1239-46. PubMed ID: 9436970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expressions of CD44 variants in tumors affecting the central nervous system.
    Resnick DK; Resnick NM; Welch WC; Cooper DL
    Mol Diagn; 1999 Sep; 4(3):219-32. PubMed ID: 10553022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.